Maternal Screening and Antiviral Therapy in Pregnant Women to Reduce Mother-to-infant Transmission of Hepatitis B Virus
Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
To investigate the efficacy of using antiviral therapy in third trimester of pregnancy to
reduce mother-to-infant HBV transmission, and to access the safety of such treatment for
mothers and infants.